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Epidermal Langerhans cells (LCs) function as the an-
tigen-presenting cells in such cutaneous cell-mediated 
immune responses as contact hypersensitivity and in the 
mixed epidermal cell-lymphocyte reaction. They have 
also been implicated in the immune response in skin 
allograft rejection. Since organ culture of thyroid and 
pancreas has been shown to prolong allograft survival, 
presumably through the loss of antigen-presenting cells, 
we examined the effect of skin explant culture on LC 
survival. Human skin explants were placed in organ 
culture and examined serially as whole mounts of epi-
dermis for the presence of LCs as judged by ATPase 
activity, and OKT-6 and HLA-DR antigens. Although we 
observed morphologic changes and an absolute reduc-
tion in the number of positively stained cells, culture for 
up to 28 days failed to deplete explants of these cells. 
Langerhans cells were also sought in the epidermal out-
growths that develop peripheral to the original explants. 
They were never seen in the area beyond 0.3 mm from 
the explant edge. Organ culture of skin thus provides a 
m eans to explore the contribution ofLCs to skin allograft 
rejection by comparing the immunogenicity of epidermal 
portions of the explant with the epidermal outgrowth. 
It h as been postulated that the presence of a subpopulation 
of bone' marrow-derived cells proba bly of m acrophage/ mono-
cyte lineage is required for the activation of T lymphocytes in 
immune responses [1]. T erm ed dendritic cells beca use of theil' 
distinct morphology, these cells have been d escribed in a wide 
variety of tissues including the spleen, ly mph node [2J, thymus 
[3] , kidney [4], and heart [5]. Epidermal Langerhans cells (LCs) 
have been shown to have morphologic a nd phenotypic proper -
ties similar to dendritic cells [6]. They, too, originate in t h e 
bone marrow [7,8] , ar e the only epidermal cells to possess C3 
a nd Fe surface m embrane receptors [9], and bear Jru'ge quanti-
t ies of class II (la-like, HLA-D/DR in huma ns) alloantigens 
[10- 12]. Functionally, LCs, like d ndritic cells, h ave been im-
plicated in initiating the immune response to antigen in contact 
h ypersensitivity [13-15] , in the mixed epidermal cell-lympho-
cyte reaction [16], and in certain viral disorders [17]. Langer-
h a ns cells also contribute to the immunogenicity of keratinizing 
tissue in allograft reactions [18,19]. 
B ecause organ culture of such tissues as the thyroid [20], 
pancreas [21], a nd ovary [22] increases allograft survival, pre-
sumably through the loss ofIa-bearing, antigen-presenting cells, 
it was of interest to observe the effect of prolonged culture of 
skin on the mor phology and numbers of LCs in human skin 
expJa nts as well as in the outgrowth of epidermis that arises 
peripheral to the explant. 
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MATERIALS AND METHODS 
Shin Tissue and Cu.lture Techniques 
Human skin was obtained from 8 adult women undergoing reduction 
mammoplasty. Explants were prepared within 24 Ill' of the surgical 
procedure using a modification of the technique of Halprin et al [23]. 
Using a Castro viejo keratome set at 0.2 mm, thin sheets of skin were 
obtained and cut into 5-mm2 explants. Two explants were placed, 
dermal side down, on a 35-mm Petri dish (Falcon) , allowed to adhere 
by drying for 15 min and then covered with 2 ml of culture medium. 
The culture medium, which was changed weekly, consisted of Eagle's 
minimum essential medium (Gibco Laboratories, Grand Island, New 
York) with 10% heat-inactivated fetal calf serum (Gibco Laboratories), 
penicillin (100 units per ml), streptomycin (100 units per ml) , ampho-
tericin B (0.25 mcg per ml) , and 0.075% NaHCO". Cultures were 
maintained at 37°C in a humidified incubator in 5% CO" in ail'. 
Langerhans Cell Identification 
Explants derived from 5 surgical specimens were examined serially 
for the presence ofLCs on days 0, 2, and 5 and at weeks I, 2, and 4 after 
having been placed in culture. Each explant was removed from the 
cul ture plate and examined as a whole mount of epidermis. Separation 
of epidermis from the underlying dermis was accomplished by incuba-
tion in EDTA at 37°C following the method of ScaJetta and MacCallum 
[24]. 
Epidermal outgrowths from 3 surgical specimens were examined at 
weeks I, 2, 3, and 4 for the presence of LCs. Outgrowths were stained 
within the Petri dish. 
Langerhans cells were identified by 3 techniq ues: ATPase histochem-
istry and direct immunofluorescence demonstrating either HLA-DH or 
OKT-6 [25] sUJ'face membrane antigens. 
ATPase histochemistry: Tissue was fixed in 4% formaldehyde wi th 
cacodylic ac id buffer and stained for nucleoside triphosphatase accord-
ing to the method of MacKenzie and Squier [26]. ExpJants were 
dehydrated thl'ough graded alcohols, followed by xylene, and mounted 
basal layer up with Permount (Fishel' Scientific Co., Fair Lawn, New 
J ersey). 
Direct immunofluorescence demonstra.ting HLA -DR a.nd OKT-6 
surface membrane antigens: Explants were s ta ined using a technique 
modified from Nordlund and Ackles [27]. Brielly, following ace tone 
fixation, epidermal whole mounts were incubated overnight at 4°C with 
100 J.L1 of either a 1:30 dilution of a monoclonal antibody to HLA-DR 
antigens (L243, a gift of R. Levy) [28] or 100 J.L l of a 1:100 dilution of a 
monoclonal antibody to the 1'6 surface membrane antigen (OK1'-6, 
Ortho Pharmaceutical Corp. , Raritan, New J ersey). Specimens were 
washed in PBS, then incubated at I'oom temperature with a 1:10 
dilution of fluoresceinated goat anti mouse IgG (Meloy Labora tories, 
Inc., Springfield, Virginia). Explants were then examined with a Leitz 
Orthoplan fluOl'escence microscope equipped with epi-illumination (E. 
Leitz, Inc., Rockleigh, New J ersey). 
Epidermal outgrowths were stained both with and without the 
central explant in place. Other than acetic ac id (0.1%) in 95% ethanol 
fixation, incubation times and dilutions of reagents were identical to 
those used for explants. However, it was necessary to use 1.0 cc of each 
reagent to allow adequate coverage of the outgrowths within the cultUl'e 
plate. Epidermal outgrowths were examined for stained cells using a 
Leitz Diavert microscope equipped with a Ploemopak 2 (luorescence 
vertical illuminator (E. Leitz, Inc. ). 
Quantitation of Langerha.ns Cells in Explants 
Langerhans cells were quantified in t he explants by 3 methods. (1) 
The percenta.ge of explant surface staining for Les was deLermined by 
scanning 5 or more low-power (200x ) microscopic fi elds on each spec-
imen. A value of 0%, 50%, 0 1' 100% was assigned to each field based on 
the proportion of the area containing positively stained cells. A per-
centage for the entire specimen wa . calcula ted from an average of' these 
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numbers. (2) Maximum concentrations of Les were obtained from the 
mean values of 4 high-power microscopic fi elds (400x) with the greatest 
number of Les. The presence of a positively stained cell body was used 
as the cri terion by which cells were counted. (3) The total tissue density 
of Les was determined for each specimen from the product of the 
percentage of explant surface staining for Les and the maximum 
concentration of Les. 
Quantitation of Langerhans Cells in the Outgrowth 
Langerhans cells were quantified in the outgrowth by counting the 
total number of cells staining within the outgrowth beyond 0.3 mm 
from the edge of the explant. 
RESULTS 
Epithelial Morphology of Human Explants 
The morphologic chamcteristics of the explant epithelium 
using this method of organ culture have been described in detail 
[29]. Briefly, the upper epidermal layers degenerated in the 
first several days of culture leaving a viable basal cell layer. In 
subsequent weeks, a secondary epithelium developed, consist-
ing of 2-3 layers of flattened basaloid cells surrounded by 
seveml cornified layers of epithelium. 
MOlphology of Langerhans Cells in Human Sllin Explants 
Prior to culture, LCs fTom each surgical specimen exhibited 
the typical dendritic morphology as identified by ATPase his-
tochemistry (Fig 1) and by direct immunofluorescence with 
monoclonal antibodies to HLA-DR (Fig 2) or OKT-6 (Fig 3) 
sill'face membrane antigens. Changes in this normal LC config-
uration became apparent within the first few days in culture. 
By day 2, the normally homogeneous HLA-DR membrane 
immunofluorescence apperu'ed discontinuous and clumped (Fig 
. 4). Within the next 2-3 days, ATPase- and immunofluores-
cence-positive material could be observed to outline many of 
the other epidermal cells in culture as if positively staining 
material had been deposited within or remained in the inter-
cellulru' space (Fig 5). Both 'ofthese changes were seen primarily 
in specimens taken early in the culture period. 
Langerhans cells also lost their typical dendritic configuration 
while in culture (Fig 6). Although some cells assumed this 
rounded shape early in culture, it was only after the first week 
FIG 1. Normal appearance of ATPase-positive dendritic cells in a 
whole mount of' epidermis prior to organ culture. X 400. 
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FIG 2. Normal appearance of dendritic cells in a whole mount of 
epidermis prior to organ cultUl'e as demonstrated by direct immuno-
fluorescence of HLA-DR antigens. X 250. 
FIG 3. Normal appearance of dendritic cells in a whole mount of 
epidermis prior to organ cultw'e as demonstrated by direct immuno-
fluorescence of OKT-6 antigens. x 250. 
that the majority of positively stained cells did so. This rounded 
form typified LCs over the remaining weeks of the culture 
period. The presence of a few dendrites and the distribution in 
the tissue were sufficiently similru' to make positively stained 
cells easily identified as LCs, thereby excluding the possibility 
that HLA-DR, OKT-6, or ATPase sUlface membrrule markers 
were being expressed by other populations of epidermal cells. 
Quantitative Changes in Langerhans Cells in Human Shin 
Explants 
Even before culture, LCs were distributed unevenly over the 
tissue surface. At that tinle the percentage of explant surface 
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FIG 4. Discontinuous and clumped appearance of LC sw-face mem-
brane HLA-DR immunoflu orescence in a 3-day explant. X 250. 
F IG 5. Deposition of HLA-DR immunoflu orescence positive mate-
rial in the in tercellular space of an explant, typ ical of the staining 
pattern seen at day 5. X 250. . 
staining for Les varied from 60% with the OKT-6 reagent to 
81% with ATPase histochemistry to 84% with the HLA-DR 
monoclonal antibody (Fig 7). Prolonged culture accentuated 
t his phenomenon. By the end of 4 weeks in culture only 11, 24, 
or 56% of the explant surface stained with t he OKT-6, ATPase, 
or HLA-DR markers, respectively. 
'T he maximum concentrations of Les declined in a parallel 
manner to that of the percent of explant surface staining for 
Les (Fig 8). Before the skin was explan ted , th ere were means 
of 640 cells/mm2 (OKT-6), 830 cells/mm2 (ATPase), and 540 
cells/mm2 (HLA-DR) in the 5 surgical specimens.· After 4 weeks 
of cul ture only 125, 280, and 380 ceUs/mm2 could be identified 
using the same 3 techniques. 
T here was also a progressive reduction in the total tissue 
density, a parameter estimating all of the positively staining 
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FIG 6. Rounded appearance of ATPase-positive cells in cul ture. By 
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FIG 7. Percentage of explant surface staining for LCs with ATPase 
histochemistry, HLA-DR immunofluorescence, and OKT-6 immuno-
fluorescence at day 0 and at 4 weeks. The results represent the mean 
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Day 0 4 Weeks 
FIG 8. Maximu m concentrations ofLCs in skin explants as identified 
by ATPase histochemistry , HLA-DR immunofluorescence, and OKT-
6 immunoflu orescence at day 0 and at 4 weeks. T he results represent 
the mean ± SEM of 4 or 5 expla nts. 
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cells in the specimen (Fig 9). The OKT-6 antigen was the least 
persistent surface membrane marker examined, falling from 410 
cells/mm2 prior to, to 15 cells/mm2 at the end of, the culture 
period . This decline in the number of OKT-6 positive cells 
became statistically significant (p = 0.012) by day 14, and this 
persisted through day 28. The ATPase sUl'face enzyme marker 
was ofintenl1ed iate sensitivity in organ culture. The total tissue 
density of ATPase-positive cells at day 0 was 675 cells/mm2. 
After 5 days in culture there was a statistically significant loss 
of ATPase-positive cells (p = 0.002), and at 4 weeks only 90 
ATPase-positive cells/mm2 could be identified. The HLA-DR 
a n t igen was most resistant to loss in culture. Of the 475 cells/ 
mm2 exhibiting that antigen prior to cul ture, 215 cell/ mm2 
contin ued to do so at the end of the cultUl'e period. Only after 
28 days was there a statistically significant difference (p = 0.04) 
compared with pre-cultme values. Thus, although there was an 
absolu te reduction in the number of positively staining cells 
within the explants, LCs did persist for the entire period of 
organ cul ture (Figs 10, 11). 
Langerhans Cells Within the Epidermal Outgrowth 
Over the initial 72 hI' following explantation, an outgrowth of 
epidermis arises peripheral to the explant by migration of 
epidermis from the original explant . Subsequent enlargement 
of that outgrowth occms almost wholly by cellular division 
[30). This epidermal outgrowth reaches maximum size by 2-3 
weeks, and may extend up to 5 mm in each direction from the 
explant edges. Rare ATPase-, HLA-DR-, and OKT-6-positive 
cells could be seen at the edge of the outgrowth adjacent to the 
original explant. However, beyond 0.3 mm from the explant 
edge only 1 OKT-6-positive cell was seen in the 11 outgrowths 
stained (Table 1). Two areas of ATPase-positive material re-
sembling cells were noted in one outgrowth. No HLA-DR-
positive cells were ever present beyond those contiguous with 
the expla nt. 
During the staining procedlll'e the epidermal outgrowth re-
mained attached to the Petri dish. To exclude the possibility 
th at the failUl'e to identify LCs in that area resulted from 
incomplete penetration of reagents, t he following positive con-
trol was used. Human serum containing antinuclear antibodies 
was incubated with the epidermal outgrowth as a substrate and 
t hen developed with a fluoresceinated rabbit ant ihuman IgG. 
Since the nuclei stained positively with this pl'ocedUl'e, failure 
to identify LCs within the epidermal outgrowth was not due to 
an inabil ity of reagents to penetrate into that tissue. 
The ina bili ty to demonstrate LCs in the major portion of the 
outgrowth is in all probability due to their absence in that al'ea; 
h owever, we cannot exclude the possibility that they are present 
there but fa il to express these characteristic markers. It may 






















FIG 9. Total tissue density of ATPase-positive, HLA-DR-positive, 
and OKT-6-positive Les in skin explants. The results represent the 
mean of 4 0 1' 5 explants. 
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FIG 10. ATPase-positive cells in an explant after 4 weeks in culture. 
x 200. 
FIG 11. HLA-DR-positive cells in an explant after 4 weeks in cul-
ture. X 250 . . 
mal outgrowth or that their phenotypic mal'kers are profoundly 
altered. 
DISCUSSION 
When hWl1an skin was placed in organ culture, LCs remained 
within the original explant and appru'ently failed to populate 
the epidermal outgrowth. As identified by ATPase histochem-
istry and by immunofluorescence with monoclonal anti-HLA-
DR and -OKT-6 antibodies, their typical dendritic configura-
tion was rapidly lost, and their normally homogeneous pattern 
of cell surface molecules was altered. Moreover, in organ cul-
tW'e, to a varying degree, these cells failed to express the 
ATPase, HLA-DR, and OKT-6 sUl'face membrane markers by 
which they were identified. 
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TABLE I. Total num.bers of positively staining cells in the 
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It has been shown that LCs contribute to the immunogenicity 
of epithelial allografts. Streilein, Toews, and Bergstresser [18] 
have observed that murine corneal epithelium (a nonkeratin-
izing epith elium similar in structure to the epidermis) lacks 
LCs. When corneal tissue is transplanted heterotopically to 
allogeneic recipients disparate only for class II antigens, the 
grafts survive for prolonged periods of time. Thus, by virtue of 
the fact that they are the only epidermal cell to synthesize Ia 
antigens, LCs have been implicated in skin allograft rejection. 
Furthermore, when allografts obtained from tape-stripped skin 
are transplanted to animals differing only in the I region of the 
major histocompatibility complex, prolonged survival is ob-
served [19]. Tape-stripping of skin has been shown to deplete 
the epidermis of LCs [31]. 
The extent to which LCs are required to process and/or 
present non-class II transplantation antigens is not fully estab-
lish ed. H-2K region differences alone have been shown to be 
sufficient to initiate allograft rejection in the mouse when non-
LC-bearing corneal tissue is used for grafting [18]. Steinmuller 
has reached similar conclusions using skin allografts differing 
at minor transplantation antigen loci [32]. 
Organ culture of other tissues, such as the thyroid [20], 
pancreas [21], and ovary [22] prolongs allograft survival pre-
sumably through the loss ofIa-bearing, antigen-presenting cells. 
In this study, we have shown that prolonged organ culture fails 
to deplete human skin explants of LCs, the antigen-presenting 
cells of the epidermis. One would therefore predict that allo-
grafts from tissue prepared in this manner would immunize the 
recipient against Ia antigens and would be rejected. If these 
findings in human tissue can be extrapolated to the murine 
system, then evidence in support of this supposition can be 
obtained from the work of Ninneman and Good [33] who found 
no prolongation of allograft survival after organ culture of 
murine skin. We have, however, shown that the epidermal 
outgrowth is in all probability devoid of LCs, and it may 
therefore be a suitable source of tissue to test the hypothesis 
that LCs are important in skin allograft rejection. 
The findings' utilizing organ culture of skin contrast with 
those of epidermal cell culture [34,35]. Cells obtained from 
epidermal cell culture after 1-2 weeks in culture fail to stimulate 
allogeneic lymphocytes in the mixed epidermal cell-lymphocyte 
reaction. Moreover, the loss of stimUlatory capacity correlates 
with the decrement in ATPase-positive and HLA-DR-positive 
cells. Although we have not tested the capacity of the skin 
placed in organ culture to stimulate allogeneic lymphocytes, 
ATPase-, OKT-6-, and HLA-DR-positive cells persist for longer 
than 4 weeks in this type of in vitro system. The fact that LCs 
do persist for prolonged periods of time in organ culture suggests 
that this type of in vitro system may be utilized to explore those 
factors that h ave a local influence on LC survival and/or 
modulate the expression of its surface membrane markers. 
Two alternatives may be proposed to explain the preferential 
location of ATPase-, HLA-DR-, and OKT-6-positive LCs within 
the explant rather than in the epidermal outgrowth. It is known 
that LCs divide infrequently [36]. Expansion of the epidermal 
outgrowth after the initial 3 days in culture occurs almost 
exclusively by cellular division. Thus, one might postulate that 
once situated within the epidermis, LCs fail to migrate to other 
areas of the epidermis lacking LCs, and that any replication of 
LCs that occurs is insufficient to populate the epidermal out-
growth. Alternatively, LCs may require the presence of adjacent 
Vol. 79, No.5 
dermis or a factor derived from the dermis for survival or for 
expression of these cell surface m arkers. Either one of these 
hypotheses could explain the observation that occasional LCs 
are found in areas of the outgrowth adjacent to the explant. 
Organ culture of skin may thus provide both a means to 
examine the role ofLCs in skin allograft rejection and a method 
to isolate those factors that locally affect LCs. 
We gratefu lly acknowledge the aid of Dr. Richard Pascoe and Ms. 
Paula Williams in procuring the sUl"gical specimens of skin, the technical 
assistance of Ms. Debbie Bate, and the careful preparation of the 
manuscript by Ms. Carol Buswell. 
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MINUTES 
General Assembly of Members of the 12th Annual Meeting of the 
European Society for Dermatological Research 
Rai-Congrescentrllln, Amsterdam, April 5, 1982 
H. HONIGSMANN, SECRETARY 
Present: Seventy-six active and senior members. 
Presidential Address: The President, M. Greaves, first paid tribute to 
the death of P rofessor G. Kalsbeek from Utrech t by observing two 
minu tes' silence which was respected by the members. He then sounded 
a gentle note of caution to the Society that, after 12 years, it had not 
increased its impact. Although the number of applicants had risen, this 
w as a poor measure of the health of the Society, and its success should 
depend on the quali ty of the science being t ransacted during its pro-
ceedings. He poin ted out that the quali ty of abstracts submitted to the 
Programme Committee was variable this year and expressed concern 
a bout some stagnation in creativity. He fe lt unhappy that there had 
b een no real involvement with nondermatological investigators in past 
m eetings; this year, however, the Programme Committee had taken a 
s m a ll step by invit ing several distinguished nondermatologists. 
Minu.tes of the 1981 General Assem.bly: T hese were approved wi thout 
dissent. 
Report of the SecretUlY: H . Honigsmann reported on the present state 
of membership. Until the deadline, November 30, 1981, 40 applications 
were recommended by the Boru·d . As of Mru'ch 31, 1982, the ESDR had 
400 members: 338 active, 52 senior, and 10 suppor ting. 
The Secretru'y also reported on the negotiations wi th Syntex, origi-
n a lly ini tiated by Malcolm Greaves, which had resul ted in regular 
a nnual support of US $5,000 for the ESDR secretariat. This grant 
covers the sa lary of a palt-time secretary. 
The Newsletter, now edited by the Secretru'y, had received disap-
point ingly little attent ion from the membership. It was established as 
a source of information and as a forum for the exchange of ideas. T he 
Secretary pointed out that he has tried to encourage people to contrib-
ute to the Newsletter and urged organizers of ESDR-sponsored meet-
ings a nd symposia to send short reports for publication. He stressed 
t h at the input had been very poor and this was reflected by the contents 
of the Newsletter which consisted mainly of organizational items. 
In order to encourage younger investigators to attend the Annual 
M eeting, graded registration fees have been fixed. For future meetings, 
it is planned to pose travel support for residents who ar e presenting a 
paper. In add it ion, the Boru'd has decided to subsidize a limi ted number 
of individuals from eastern E uropean countries with currency difficul-
ties. The national Dermatological Societies have been informed of this 
decision. 
Effective June 15, 1982, Dr. Howru'd P . Baden from Harvru'd Medical 
School, Boston, will be the Editor of the JID. As the ESDR members 
of' the Editoria l Boru'd, he has appoin ted Dr. Chru'les Lapiere as 
European Chief Editor, and Drs. Rona MacKie and Georg Stingl as 
coeditors. Dr. Lapiere will attend future ESDR Board meetings as a 
coopted member. 
T he Secretru·y thanked Drs. Frenk, Schaefer, and van Joost for their 
help in amending the statutes. 
R eport of the Treasu.rer: W. van Vloten reported on the expenses and 
income of the last year. T he credit balance stood at Fl. 31,636.46 
(savings accoun t - Fl. 80,000.00) . He pointed out that, due to economic 
problems, there might have to be an increase in the subscription fee. 
The Treasurer's repor t was accepted withou t dissent. 
R eport of the Programme Com.mittee (M. Greaves, Chai.rman, G. 
P lewig, A. Giannetti) : For the first time, a central theme was chosen 
for the Annual Meeting: The P hru'macology of Inflammation. The 
Committee would, however, value written or verbal comments from 
members on whether to continue with this practice. Of the abstracts 
received for the 1982 Meeting, approximately 50% had been accepted. 
M. Greaves further commented on the fact that some posters, which 
had been accepted for presentation, had all'eady been presented two 
days previously at the MeetiJlg of the Society for Cutaneous Ultrastruc-
tive Research. Although the rules state only that material must not be 
presented before submission, this pract:ice apperu'ed nevertheless highly 
undesirable. 
R eport of the Editor of The Journal of Investiga.tive Derma.tology: M. 
Greaves welcomed both officers of the forthcoming Boru'd of the JID, 
Howard P. Baden and Chru'les Lapihe, to the Meeting and wished 
them every success for the fu ture. 
G. P lewig reported on Ruth Freinkel's annual report and quoted two 
letters, the Editorial Boru'd Meeting note of December 1981 and the 
Editorial Report. According to the financial position of the JID, an 
increase from $40 to $45 in the subscript ion would be necessary to 
adjust to inflation. In order to publish 50% of unsolicited manuscripts 
submitted to the Journal, the JID would require an additional 100 
pages in 1983. T his could be financed as follows: 1) increase in the 
subscript ion rate, 2) chru'ging a submission fee , or 3) charging a fee for 
publication. 
In a lively debate, the Membership strongly opposed a page chru·ge. 
